ONCODESIGN PRECISION MEDICIN (ALOPM.PA) Stock Analyst Ratings
Europe - EPA:ALOPM - FR001400CM63 - Common Stock
0.458 EUR
-0.01 (-1.29%)
ChartMill assigns a Buy % Consensus number of 84% to ALOPM.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is 345.41% above the current price.
ALOPM.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALOPM.PA.
In the previous month the buy percentage consensus was at a similar level.
ALOPM.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
ONCODESIGN PRECISION MEDICIN / ALOPM.PA FAQ
What is the average price target for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) stock?
9 analysts have analysed ALOPM.PA and the average price target is 2.04 EUR. This implies a price increase of 345.41% is expected in the next year compared to the current price of 0.458.
Can you provide the consensus rating for ONCODESIGN PRECISION MEDICIN stock?
The consensus rating for ONCODESIGN PRECISION MEDICIN (ALOPM.PA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for ALOPM stock?
The number of analysts covering ONCODESIGN PRECISION MEDICIN (ALOPM.PA) is 9.